Global Prenatal and New-born Genetic Testing Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Publication Month: Feb 2020 | No. of Pages: 107 Published By: Global Info Research
Single User License: US $ 3480
Corporate User License: US $ 6960

Market Overview
The global Prenatal and New-born Genetic Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.6% in the forecast period of 2020 to 2025 and will expected to reach USD 4849.6 million by 2025, from USD 3752.8 million in 2019.

The Prenatal and New-born Genetic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Prenatal and New-born Genetic Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Prenatal and New-born Genetic Testing market has been segmented into:
PCR
FISH
aCGH
NIPT
MSS

By Application, Prenatal and New-born Genetic Testing has been segmented into:
Hospital
Clinic
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Prenatal and New-born Genetic Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Prenatal and New-born Genetic Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Prenatal and New-born Genetic Testing market.

The report offers in-depth assessment of the growth and other aspects of the Prenatal and New-born Genetic Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Prenatal and New-born Genetic Testing Market Share Analysis
Prenatal and New-born Genetic Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Prenatal and New-born Genetic Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Prenatal and New-born Genetic Testing sales, revenue and market share for each player covered in this report.

The major players covered in Prenatal and New-born Genetic Testing are:
Agilent Technologies, Inc.
Sequenom, Inc.
Illumina, Inc.
Bio-Rad Laboratories, Inc.
Verinata Health
Natera, Inc.
Perkin Elmer
Ariosa Diagnostics

Table of Contents

1 Prenatal and New-born Genetic Testing Market Overview
1.1 Product Overview and Scope of Prenatal and New-born Genetic Testing
1.2 Classification of Prenatal and New-born Genetic Testing by Type
1.2.1 Global Prenatal and New-born Genetic Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Prenatal and New-born Genetic Testing Revenue Market Share by Type in 2019
1.2.3 PCR
1.2.4 FISH
1.2.5 aCGH
1.2.6 NIPT
1.2.7 MSS
1.3 Global Prenatal and New-born Genetic Testing Market by Application
1.3.1 Overview: Global Prenatal and New-born Genetic Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Prenatal and New-born Genetic Testing Market by Regions
1.4.1 Global Prenatal and New-born Genetic Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Prenatal and New-born Genetic Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Prenatal and New-born Genetic Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Prenatal and New-born Genetic Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Prenatal and New-born Genetic Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Prenatal and New-born Genetic Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Prenatal and New-born Genetic Testing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Agilent Technologies, Inc.
2.1.1 Agilent Technologies, Inc. Details
2.1.2 Agilent Technologies, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Agilent Technologies, Inc. SWOT Analysis
2.1.4 Agilent Technologies, Inc. Product and Services
2.1.5 Agilent Technologies, Inc. Prenatal and New-born Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sequenom, Inc.
2.2.1 Sequenom, Inc. Details
2.2.2 Sequenom, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sequenom, Inc. SWOT Analysis
2.2.4 Sequenom, Inc. Product and Services
2.2.5 Sequenom, Inc. Prenatal and New-born Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Illumina, Inc.
2.3.1 Illumina, Inc. Details
2.3.2 Illumina, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Illumina, Inc. SWOT Analysis
2.3.4 Illumina, Inc. Product and Services
2.3.5 Illumina, Inc. Prenatal and New-born Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bio-Rad Laboratories, Inc.
2.4.1 Bio-Rad Laboratories, Inc. Details
2.4.2 Bio-Rad Laboratories, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bio-Rad Laboratories, Inc. SWOT Analysis
2.4.4 Bio-Rad Laboratories, Inc. Product and Services
2.4.5 Bio-Rad Laboratories, Inc. Prenatal and New-born Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Verinata Health
2.5.1 Verinata Health Details
2.5.2 Verinata Health Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Verinata Health SWOT Analysis
2.5.4 Verinata Health Product and Services
2.5.5 Verinata Health Prenatal and New-born Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Natera, Inc.
2.6.1 Natera, Inc. Details
2.6.2 Natera, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Natera, Inc. SWOT Analysis
2.6.4 Natera, Inc. Product and Services
2.6.5 Natera, Inc. Prenatal and New-born Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Perkin Elmer
2.7.1 Perkin Elmer Details
2.7.2 Perkin Elmer Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Perkin Elmer SWOT Analysis
2.7.4 Perkin Elmer Product and Services
2.7.5 Perkin Elmer Prenatal and New-born Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.8 Ariosa Diagnostics
2.8.1 Ariosa Diagnostics Details
2.8.2 Ariosa Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Ariosa Diagnostics SWOT Analysis
2.8.4 Ariosa Diagnostics Product and Services
2.8.5 Ariosa Diagnostics Prenatal and New-born Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Prenatal and New-born Genetic Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Prenatal and New-born Genetic Testing Players Market Share
3.2.2 Top 10 Prenatal and New-born Genetic Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Prenatal and New-born Genetic Testing Revenue and Market Share by Regions
4.2 North America Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
4.3 Europe Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
4.5 South America Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
5 North America Prenatal and New-born Genetic Testing Revenue by Countries
5.1 North America Prenatal and New-born Genetic Testing Revenue by Countries (2015-2020)
5.2 USA Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
5.3 Canada Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
6 Europe Prenatal and New-born Genetic Testing Revenue by Countries
6.1 Europe Prenatal and New-born Genetic Testing Revenue by Countries (2015-2020)
6.2 Germany Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
6.3 UK Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
6.4 France Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
6.5 Russia Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
6.6 Italy Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Prenatal and New-born Genetic Testing Revenue by Countries
7.1 Asia-Pacific Prenatal and New-born Genetic Testing Revenue by Countries (2015-2020)
7.2 China Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
7.3 Japan Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
7.4 Korea Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
7.5 India Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
8 South America Prenatal and New-born Genetic Testing Revenue by Countries
8.1 South America Prenatal and New-born Genetic Testing Revenue by Countries (2015-2020)
8.2 Brazil Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Prenatal and New-born Genetic Testing by Countries
9.1 Middle East & Africa Prenatal and New-born Genetic Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
9.3 UAE Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Prenatal and New-born Genetic Testing Revenue and Market Share by Type (2015-2020)
10.2 Global Prenatal and New-born Genetic Testing Market Forecast by Type (2019-2024)
10.3 PCR Revenue Growth Rate (2015-2025)
10.4 FISH Revenue Growth Rate (2015-2025)
10.5 aCGH Revenue Growth Rate (2015-2025)
10.6 NIPT Revenue Growth Rate (2015-2025)
10.7 MSS Revenue Growth Rate (2015-2025)
11 Global Prenatal and New-born Genetic Testing Market Segment by Application
11.1 Global Prenatal and New-born Genetic Testing Revenue Market Share by Application (2015-2020)
11.2 Prenatal and New-born Genetic Testing Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Prenatal and New-born Genetic Testing Market Size Forecast (2021-2025)
12.1 Global Prenatal and New-born Genetic Testing Market Size Forecast (2021-2025)
12.2 Global Prenatal and New-born Genetic Testing Market Forecast by Regions (2021-2025)
12.3 North America Prenatal and New-born Genetic Testing Revenue Market Forecast (2021-2025)
12.4 Europe Prenatal and New-born Genetic Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Prenatal and New-born Genetic Testing Revenue Market Forecast (2021-2025)
12.6 South America Prenatal and New-born Genetic Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Prenatal and New-born Genetic Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

Tables and Figures

List of Tables

Table 1. Global Prenatal and New-born Genetic Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Prenatal and New-born Genetic Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Prenatal and New-born Genetic Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Prenatal and New-born Genetic Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Agilent Technologies, Inc. Corporate Information, Location and Competitors
Table 6. Agilent Technologies, Inc. Prenatal and New-born Genetic Testing Major Business
Table 7. Agilent Technologies, Inc. Prenatal and New-born Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 8. Agilent Technologies, Inc. SWOT Analysis
Table 9. Agilent Technologies, Inc. Prenatal and New-born Genetic Testing Product and Solutions
Table 10. Agilent Technologies, Inc. Prenatal and New-born Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Sequenom, Inc. Corporate Information, Location and Competitors
Table 12. Sequenom, Inc. Prenatal and New-born Genetic Testing Major Business
Table 13. Sequenom, Inc. Prenatal and New-born Genetic Testing Total Revenue (USD Million) (2018-2019)
Table 14. Sequenom, Inc. SWOT Analysis
Table 15. Sequenom, Inc. Prenatal and New-born Genetic Testing Product and Solutions
Table 16. Sequenom, Inc. Prenatal and New-born Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Illumina, Inc. Corporate Information, Location and Competitors
Table 18. Illumina, Inc. Prenatal and New-born Genetic Testing Major Business
Table 19. Illumina, Inc. Prenatal and New-born Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 20. Illumina, Inc. SWOT Analysis
Table 21. Illumina, Inc. Prenatal and New-born Genetic Testing Product and Solutions
Table 22. Illumina, Inc. Prenatal and New-born Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bio-Rad Laboratories, Inc. Corporate Information, Location and Competitors
Table 24. Bio-Rad Laboratories, Inc. Prenatal and New-born Genetic Testing Major Business
Table 25. Bio-Rad Laboratories, Inc. Prenatal and New-born Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 26. Bio-Rad Laboratories, Inc. SWOT Analysis
Table 27. Bio-Rad Laboratories, Inc. Prenatal and New-born Genetic Testing Product and Solutions
Table 28. Bio-Rad Laboratories, Inc. Prenatal and New-born Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Verinata Health Corporate Information, Location and Competitors
Table 30. Verinata Health Prenatal and New-born Genetic Testing Major Business
Table 31. Verinata Health Prenatal and New-born Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 32. Verinata Health SWOT Analysis
Table 33. Verinata Health Prenatal and New-born Genetic Testing Product and Solutions
Table 34. Verinata Health Prenatal and New-born Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Natera, Inc. Corporate Information, Location and Competitors
Table 36. Natera, Inc. Prenatal and New-born Genetic Testing Major Business
Table 37. Natera, Inc. Prenatal and New-born Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 38. Natera, Inc. SWOT Analysis
Table 39. Natera, Inc. Prenatal and New-born Genetic Testing Product and Solutions
Table 40. Natera, Inc. Prenatal and New-born Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Perkin Elmer Corporate Information, Location and Competitors
Table 42. Perkin Elmer Prenatal and New-born Genetic Testing Major Business
Table 43. Perkin Elmer Prenatal and New-born Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 44. Perkin Elmer SWOT Analysis
Table 45. Perkin Elmer Prenatal and New-born Genetic Testing Product and Solutions
Table 46. Perkin Elmer Prenatal and New-born Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Ariosa Diagnostics Corporate Information, Location and Competitors
Table 48. Ariosa Diagnostics Prenatal and New-born Genetic Testing Major Business
Table 49. Ariosa Diagnostics Prenatal and New-born Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 50. Ariosa Diagnostics SWOT Analysis
Table 51. Ariosa Diagnostics Prenatal and New-born Genetic Testing Product and Solutions
Table 52. Ariosa Diagnostics Prenatal and New-born Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Prenatal and New-born Genetic Testing Revenue (Million USD) by Players (2015-2020)
Table 54. Global Prenatal and New-born Genetic Testing Revenue Share by Players (2015-2020)
Table 55. Global Prenatal and New-born Genetic Testing Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Prenatal and New-born Genetic Testing Revenue Market Share by Regions (2015-2020)
Table 57. North America Prenatal and New-born Genetic Testing Revenue by Countries (2015-2020)
Table 58. North America Prenatal and New-born Genetic Testing Revenue Market Share by Countries (2015-2020)
Table 59. Europe Prenatal and New-born Genetic Testing Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Prenatal and New-born Genetic Testing Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Prenatal and New-born Genetic Testing Revenue by Countries (2015-2020)
Table 62. South America Prenatal and New-born Genetic Testing Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Prenatal and New-born Genetic Testing Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Prenatal and New-born Genetic Testing Revenue Market Share by Countries (2015-2020)
Table 65. Global Prenatal and New-born Genetic Testing Revenue (Million USD) by Type (2015-2020)
Table 66. Global Prenatal and New-born Genetic Testing Revenue Share by Type (2015-2020)
Table 67. Global Prenatal and New-born Genetic Testing Revenue Forecast by Type (2021-2025)
Table 68. Global Prenatal and New-born Genetic Testing Revenue by Application (2015-2020)
Table 69. Global Prenatal and New-born Genetic Testing Revenue Share by Application (2015-2020)
Table 70. Global Prenatal and New-born Genetic Testing Revenue Forecast by Application (2021-2025)
Table 71. Global Prenatal and New-born Genetic Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Prenatal and New-born Genetic Testing Picture
Figure 2. Global Prenatal and New-born Genetic Testing Revenue Market Share by Type in 2019
Figure 3. PCR Picture
Figure 4. FISH Picture
Figure 5. aCGH Picture
Figure 6. NIPT Picture
Figure 7. MSS Picture
Figure 8. Prenatal and New-born Genetic Testing Revenue Market Share by Application in 2019
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Others Picture
Figure 12. Global Prenatal and New-born Genetic Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Prenatal and New-born Genetic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Prenatal and New-born Genetic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Prenatal and New-born Genetic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Prenatal and New-born Genetic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Prenatal and New-born Genetic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Prenatal and New-born Genetic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Prenatal and New-born Genetic Testing Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Prenatal and New-born Genetic Testing Revenue Market Share in 2019
Figure 21. Global Top 10 Players Prenatal and New-born Genetic Testing Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Prenatal and New-born Genetic Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Prenatal and New-born Genetic Testing Revenue Market Share by Regions (2015-2020)
Figure 25. Global Prenatal and New-born Genetic Testing Revenue Market Share by Regions in 2018
Figure 26. North America Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 27. Europe Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 29. South America Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 31. North America Prenatal and New-born Genetic Testing Revenue Market Share by Countries (2015-2020)
Figure 32. North America Prenatal and New-born Genetic Testing Revenue Market Share by Countries in 2019
Figure 33. USA Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 34. Canada Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 36. Europe Prenatal and New-born Genetic Testing Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Prenatal and New-born Genetic Testing Revenue Market Share by Countries in 2019
Figure 38. Germany Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 39. UK Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 40. France Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 41. Russia Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 42. Italy Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Prenatal and New-born Genetic Testing Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Prenatal and New-born Genetic Testing Revenue Market Share by Countries in 2019
Figure 45. China Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 46. Japan Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 47. Korea Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 48. India Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 50. South America Prenatal and New-born Genetic Testing Revenue Market Share by Countries (2015-2020)
Figure 51. South America Prenatal and New-born Genetic Testing Revenue Market Share by Countries in 2019
Figure 52. Brazil Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Prenatal and New-born Genetic Testing Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Prenatal and New-born Genetic Testing Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 57. UAE Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Prenatal and New-born Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 60. Global Prenatal and New-born Genetic Testing Revenue Share by Type (2015-2020)
Figure 61. Global Prenatal and New-born Genetic Testing Revenue Share by Type in 2019
Figure 62. Global Prenatal and New-born Genetic Testing Market Share Forecast by Type (2021-2025)
Figure 63. Global PCR Revenue Growth Rate (2015-2020)
Figure 64. Global FISH Revenue Growth Rate (2015-2020)
Figure 65. Global aCGH Revenue Growth Rate (2015-2020)
Figure 66. Global NIPT Revenue Growth Rate (2015-2020)
Figure 67. Global MSS Revenue Growth Rate (2015-2020)
Figure 68. Global Prenatal and New-born Genetic Testing Revenue Share by Application (2015-2020)
Figure 69. Global Prenatal and New-born Genetic Testing Revenue Share by Application in 2019
Figure 70. Global Prenatal and New-born Genetic Testing Market Share Forecast by Application (2021-2025)
Figure 71. Global Hospital Revenue Growth Rate (2015-2020)
Figure 72. Global Clinic Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Prenatal and New-born Genetic Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Prenatal and New-born Genetic Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Prenatal and New-born Genetic Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Prenatal and New-born Genetic Testing Revenue Market Forecast (2021-2025)
Figure 78. Europe Prenatal and New-born Genetic Testing Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Prenatal and New-born Genetic Testing Revenue Market Forecast (2021-2025)
Figure 80. South America Prenatal and New-born Genetic Testing Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Prenatal and New-born Genetic Testing Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel




Companies Mentioned
Agilent Technologies, Inc.
Sequenom, Inc.
Illumina, Inc.
Bio-Rad Laboratories, Inc.
Verinata Health
Natera, Inc.
Perkin Elmer
Ariosa Diagnostics

Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets